The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury.
Open accessAbstract
The ability of beta cells to endure assaults may be relevant in the development of insulin-dependent diabetes mellitus. This study examines the susceptibility of human pancreatic islets to agents that are cytotoxic for rodent beta cells--i.e., sodium nitroprusside (NP, a nitric oxide donor), streptozotocin (SZ), or alloxan. After 5-8 days in tissue culture, human or rodent islets were exposed for 14 h to NP (50-200 microM) or for 30 min to SZ or alloxan (1-3 mM). Glucose oxidation by human islets was not reduced by NP, but there was a dose-dependent inhibition in rat (40-90% inhibition; P < 0.001) and mouse (10-60% inhibition; P < 0.05) islet glucose oxidation. Glucose (16.7 mM)-induced insulin release by human islets was not impaired after a 30-min exposure to SZ or alloxan, at concentrations that inhibited insulin release from rat (30-80% inhibition; P < 0.001) or mouse (10-70% inhibition; P < 0.05) islets. The viability of human beta cells purified by flow cytometry was not affected by SZ or alloxan (5 mM), as judged 1 or 4 days after a 10-min exposure and subsequent culture; these conditions were cytotoxic for rat beta cells, with 65-95% (P < 0.01) dead beta cells after 4 days. Human islets transplanted under the kidney capsule of nude mice were not affected by in vivo alloxan exposure, as suggested by preserved graft morphology and insulin content, whereas the endogenous beta cells of the transplanted mice were severely damage (80% decrease in pancreatic insulin content and morphological signs of beta-cell destruction). Thus human beta cells are resistant to NP, SZ, or alloxan at concentrations that decrease survival and function of rat or mouse beta cells. These marked interspecies differences emphasize the relevance of repair and/or defense mechanisms in beta-cell destruction and raise the possibility that such differences may also be present among individuals of the same species.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eisenbarth (1986) · doi:10.1056/nejm198605223142106 · Cited by 1,659
Feelisch, M., & Noack, E. A. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90493-6 · Cited by 888
A New in Vitro Model for the Study of Pancreatic A and B Cells*
PIPELEERS, D. G., IN’T VELD, P. A., WINKEL, M. V. D., MAES, E., SCHUIT, F. C., & GEPTS, W. (1985) · Endocrinology · doi:10.1210/endo-117-3-806 · Cited by 341
Self-citationCytokines suppress human islet function irrespective of their effects on nitric oxide generation.
Eizirik, D. L., Sandler, S., Welsh, N., Cetkovic-Cvrlje, M., Nieman, A., Geller, D. A., Pipeleers, D. G., Bendtzen, K., & Hellerström, C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117188 · Cited by 317
Self-citationEizirik, D. L., Korbutt, G. S., & Hellerström, C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115989 · Cited by 311
Self-citationCorbett, J. A., & McDaniel, M. L. (1992) · Diabetes · doi:10.2337/diab.41.8.897 · Cited by 297
Andersson, A. (1978) · Diabetologia · doi:10.1007/bf01228134 · Cited by 282
Self-citationCytokines and Free Radicals as Effector Molecules in the Destruction of Pancreatic Beta Cells
Mandrup-Poulsen, T., Helqvist, S., Wogensen, L. D., Mølvig, J., Pociot, F., Johannesen, J., & Nerup, J. (1990) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-75741-9_9 · Cited by 184
It was a very good year for DNA repair
Cleaver, J. E. (1994) · Cell · doi:10.1016/0092-8674(94)90165-1 · Cited by 178
Alloxan toxicity to the pancreatic B-cell
Malaisse, W. J. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90571-8 · Cited by 158
Cited by
The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas
Szkudelski, T. (2001) · Physiological Research · doi:10.33549/physiolres.930111 · Cited by 2,876
Kroon, E., Martinson, L. A., Kadoya, K., Bang, A. G., Kelly, O. G., Eliazer, S., Young, H., Richardson, M., Smart, N. G., Cunningham, J., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1393 · Cited by 1,843
The use of animal models in diabetes research
King, A. J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01911.x · Cited by 1,303
Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus
Westermark, P., Andersson, A., & Westermark, G. T. (2011) · Physiological Reviews · doi:10.1152/physrev.00042.2009 · Cited by 1,044
“When human islets, isolated by fairly reproducible techniques, became available, such recipients, normoglycemic or made diabetic by injections of alloxan or streptozotocin, were used in studies of effects of hyperglycemia on human -cell function (96, 161), replication (359, 361), or susceptibility to -cell toxic agent…”
MethodSelf-citationβ-Cell death during progression to diabetes
Mathis, D., Vence, L., & Benoist, C. (2001) · Nature · doi:10.1038/414792a · Cited by 884
The Role of Oxidative Stress and Hypoxia in Pancreatic Beta-Cell Dysfunction in Diabetes Mellitus
Gerber, P. A., & Rutter, G. A. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6755 · Cited by 654
“Thus, early studies suggested a superior antioxidant capability of human islets compared to rodent islets (42, 43, 205).”
Inducible nitric oxide synthase in human diseases
Kröncke, K.-D., Fehsel, K., & Kolb-Bachofen, V (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1998.00648.x · Cited by 585
A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion
Ravassard, P., Hazhouz, Y., Pechberty, S., Bricout-Neveu, E., Armanet, M., Czernichow, P., & Scharfmann, R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58447 · Cited by 576
The role of interleukin-1 in the pathogenesis of IDDM
Mandrup-Poulsen, T. (1996) · Diabetologia · doi:10.1007/bf00400649 · Cited by 543
Eizirik, D. L., Sammeth, M., Bouckenooghe, T., Bottu, G., Sisino, G., Igoillo-Esteve, M., Ortis, F., Santin, I., Colli, M. L., Barthson, J., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002552 · Cited by 465
Self-citationSchulz, T. C., Young, H. Y., Agulnick, A. D., Babin, M. J., Baetge, E. E., Bang, A. G., Bhoumik, A., Cepa, I., Cesario, R. M., Haakmeester, C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037004 · Cited by 428
Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression.
De Vos, A., Heimberg, H., Quartier, E., Huypens, P., Bouwens, L., Pipeleers, D., & Schuit, F. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118308 · Cited by 425
Self-citationGrowth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells
Hori, Y., Rulifson, I. C., Tsai, B. C., Heit, J. J., Cahoy, J. D., & Kim, S. K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252618999 · Cited by 421
Cytokines Induce Deoxyribonucleic Acid Strand Breaks and Apoptosis in Human Pancreatic Islet Cells
Delaney, C. A., Pavlović, D., Hoorens, A., PIPELEERS, D. G., & Eizirik, D. L. (1997) · Endocrinology · doi:10.1210/en.138.6.2610 · Cited by 320
Self-citationEizirik, D. L., Flodström, M., Karlsen, A. E., & Welsh, N. (1996) · Diabetologia · doi:10.1007/bf00403906 · Cited by 319
Self-citationOxidative stress and beta-cell dysfunction
Drews, G., Krippeit-Drews, P., & Düfer, M. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0862-9 · Cited by 315
The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis
Padgett, L. E., Broniowska, K. A., Hansen, P. A., Corbett, J. A., & Tse, H. M. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06826.x · Cited by 288
Seufert, J., Kieffer, T. J., Leech, C. A., Holz, G. G., Moritz, W., Ricordi, C., & Habener, J. F. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5460 · Cited by 278
Involvement of Oxidative Stress in the Pathogenesis of Diabetes
Kaneto, H., Katakami, N., Kawamori, D., Miyatsuka, T., Sakamoto, K., Matsuoka, T.-A., Matsuhisa, M., & Yamasaki, Y. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.1465 · Cited by 263
Nutrient Control of Insulin Secretion in Isolated Normal Human Islets
Henquin, J.-C., Dufrane, D., & Nenquin, M. (2006) · Diabetes · doi:10.2337/db06-0868 · Cited by 228
Marroqui, L., Dos Santos, R. S., Op de beeck, A., Coomans de Brachène, A., Marselli, L., Marchetti, P., & Eizirik, D. L. (2017) · Diabetologia · doi:10.1007/s00125-016-4201-3 · Cited by 203
Self-citationArcidiacono, B., Iiritano, S., Chiefari, E., Brunetti, F. S., Gu, G., Foti, D. P., & Brunetti, A. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00237 · Cited by 68
Antiapoptotic Actions of Exendin-4 against Hypoxia and Cytokines Are Augmented by CREB
Velmurugan, K., Balamurugan, A. N., Loganathan, G., Ahmad, A., Hering, B. J., & Pugazhenthi, S. (2012) · Endocrinology · doi:10.1210/en.2011-1895 · Cited by 53
Dos Santos, R. S., Medina-Gali, R. M., Babiloni-Chust, I., Marroqui, L., & Nadal, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095040 · Cited by 28
Scharfmann, R. (2008) · Diabetologia · doi:10.1007/s00125-007-0909-4 · Cited by 9
Metadata
- Authors
- Eizirik, D. L., Pipeleers, D. G., Ling, Z., Welsh, N., Hellerström, C., & Andersson, A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1994-09-27
- Volume
- 91
- Issue
- 20
- Pages
- 9253-9256
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2012549875
- Cited by
- 261
- References
- 15
- FWCI
- 11.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.